3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
13
Advanced Solid Tumors
6
Solid Tumors
5
Advanced Solid Tumor
5
Solid Tumor
4
Mesothelioma
2
Triple Negative Breast Neoplasms
1
Thymoma
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Retinoblastoma
1
Resectable Colon Cancer
1
Pseudomyxoma Peritonei
1
Peritoneal Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Melanoma
1
Malignant Solid Tumour
1
MSI-H Advanced Colorectal Cancer
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Choroid Plexus Neoplasms
1
Childhood Central Nervous System Choriocarcinoma
1
Central Nervous System Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cyclophosphamide
2
Celecoxib
2
pembrolizumab
1
olaparib
1
fludarabine
1
entinostat
1
bosutinib
1
Radiofrequency Ablation
1
Psychiatric Rehabilitation
1
Pemetrexed
1
Leucovorin
1
Imatinib Mesylate
1
Fentanyl
1
FANG vaccine
1
Early Intervention, Educational
1
Doxepin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thymoma
×
Leucovorin
×
Other solid neoplasm
×
Clear all
NCT06010277
2023-08-24
FLEX
Amphia Hospital
Phase 4
Unknown
50 enrolled